Digital infarction in a patient with Raynaud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor: A case report

Angiology

Volumn 47, Issue 9, 1996, Pages 901-903

  Bell, Caroline ^a   Coupland, Nicholas ^b   Creamer, Paul ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FINGER JOINT; HUMAN; HYPEREMIA; INFARCTION; RAYNAUD PHENOMENON; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE; VASOSPASM;

EID: 0029787078     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979604700909     Document Type: Article

References (11)

1. Biondi ML, Marasini B, Blanchi E, et al: Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol 19:335-339, 1988.
2. Arneklo-Nobin B, Elmer O, Akesson A, et al: Effect of long term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. Int Angiol 7:19- 25, 1988.
3. Winkelmann RK, Goldyne ME, Linscheid RL, et al: Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-HT. Br J Dermatol 95:51-56, 1976.
4. Moulds RFW, Iwanov V, Medcalf R, et al: The effects of platelet-derived contractile agents on human digital arteries. Clin Sci 66:443-451, 1984.
5. Roddie IC, Shepherd JT, Whelan RF, et al: The action of 5-HT on the blood vessels of the human hand and forearm. Br J Pharmacol 10:445-450, 1955.
6. 2 receptor antagonist ketanserin. Br Med J 285:1069-1071, 1982.
7. Ortiz J, Artigas F: Effects of monoamine uptake inhibitors on extracellular and platelet 5-HT in rat blood: Different effects of clomipramine and fluoxetine. Br J Pharmacol 105:941-946, 1992.
8. Celada P, Dolera M, Alvarez E, et al: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affective Disorders 25:243-250, 1992.
9. Wigley EM, Wise RA, Siebold JR, et al: Intravenous iloprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis. Ann Intern Med 120:199-206, 1994.
10. Berger M, Massardier A: Aspects of treating depressive states in the very elderly with the combination of perfusions, antidepressants and medical care. Actualies Psychiat (F) (5):71-79, 1976.
11. Bolte MA, Avery D: Case of fluoxetine-induced remission of Raynaud's phenomenon - a case report. Angiology 44:161-163, 1993.